Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CD19L-sTRAIL fusion protein, human

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To investigate the inhibitory effect of MenSC-sTRAIL on the apoptosis of A549 cells of lung cancer in a nude mouse… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
Patients with B cell precursor acute lymphoblastic leukemia (BPL) respond well to chemotherapy at initial diagnosis; however… Expand
Is this relevant?
2015
2015
Mesenchymal stem cells (MSCs) are believed to be a potential vehicle delivering antitumor agents for their tumor-homing capacity… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
In high-risk remission B-precursor acute lymphoblastic leukemia (BPL) patients, relapse rates have remained high post… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively kill tumor cells and enhance therapy in vivo… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
OBJECTIVES Soluble tumor necrosis factor-related apoptosis-inducing ligand (sTRAIL) has been shown to have both pro- and anti… Expand
  • table 2
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2013
2013
Mesenchymal stem cells (MSCs) are an attractive candidate for cell-based therapy. We have designed a promising double-target… Expand
Is this relevant?
2008
2008
OBJECTIVE To evaluate the impact of the recombined adeno-associated virus encoding soluble tumor necrosis factor related… Expand
Is this relevant?
2006
2006
BACKGROUND Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces cell death in various tumor cells, but… Expand
Is this relevant?